Orchestra Biomed Holdings Inc (OBIO) - News Archive

Showing 3 of 3 results.

Orchestra BioMed to Unveil Breakthrough Hypertensive Pacemaker Therapy Program at In-Person R&D Day in New York

Orchestra BioMed Holdings, an innovative biomedical company, has announced that it will be hosting an exclusive in-person Research and Development (R&D) day on June 11, 2024, at the prestigious Lotte New York Palace Hot...

Apr 30, 2024 • Medical Equipment & Supplies Industry Announcement

Atrioventricular Interval Modulation (AVIM) Therapy Demonstrates Favorable Hemodynamic Effects in Hypertensive Pacemaker Patients

Orchestra BioMed Holdings, Inc. recently conducted a clinical study to evaluate the efficacy of Atrioventricular Interval Modulation (AVIM) therapy, also known as BackBeat CNT, in pacemaker-indicated patients with uncon...

Mar 6, 2024 • Medical Equipment & Supplies Industry Clinical Study

Evaluating the Efficacy and Safety of Atrioventricular Interval Modulation Therapy for Hypertensive Pacemaker Patients: The BACKBEAT Pivotal Study

- Hypertension remains a significant global health concern, affecting millions of individuals worldwide.- Conventional pharmacological therapies for hypertension may not always effectively control blood pressure in cert...

Jan 8, 2024 • Medical Equipment & Supplies Industry Clinical Study